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Abstract
Background: Heat shock proteins are acute phase proteins that are upregulated in inflammation or following
thermal stress. We analyzed the presence of the heat shock protein 70 (Hsp 70) in choroidal neovascular (CNV)
membranes secondary to AMD after treatment with verteporphin photodynamic therapy (PDT) or transpupillary
thermo therapy (TTT) to determine whether treatment correlated with the presence of Hsp70.
Results: CNV membranes were removed by pars plana vitrectomy (ppV) and subretinal extraction. The membranes
were analysed by light microscopy and the presence of Hsp 70 was examined using histochemistry. HeLa Cells
served as controls.
Of the 14 membranes analysed 11 were Hsp70 positive and 3 negative. In the no pre-treatment group of 8
membranes 6 were Hsp70 positive and 2 negative; in the PTD group all 4 membranes were positive and in the
TTT group 1 membrane was positive and 1 membrane was negative for Hsp70.
Conclusion: Hsp70 is present in the most CNV membranes secondary to AMD. Pre-treatment of the membrane
with PTD or TTT does not appear to influence the expression of Hsp70.
Background
Choroidal neovascularization (CNV) is the leading
cause of severe visual impairment in patients with age-
related macular degeneration (AMD) since when left
untreated CNV leads to disciform scarring of the
macula [1,2].
Several therapeutic strategies have been attempted to
reduce the destructive effects of CNV membranes and
stabilize vision. Since 2006 the preferred treatment for
neovascular AMD is the intravitreal injections of inhibi-
tors of VGF’s especially the monoclonal antibodies beva-
cizumab (Avastin
®) and ranibizumab (Lucentis
®) [3,4].
Photodynamic therapy (PDT), submacular surgery and
laser procedures have become second line options.
While argon laser photocoagulation destroys the CNV
and overlying retina, transpupillary thermotherapy
(TTT) has been thought to selectively damage the CNV
by hyperthermia, inducing thrombotic vessel occlusion
while sparing the overlying retina [5].
Heat shock proteins function as intra-cellular chaper-
ones for other proteins and play a critical role in pro-
tein-protein interactions, assist in generating proper
protein conformation and prevent pathological protein
aggregation. Hsp proteins are expressed under physiolo-
gical condition in all organisms and play an essential
role in protein maintenance [6,7].
Hsp70’s are a family of proteins that, as other heat
shock proteins, aid in protein folding and stabilization.
Hsp70’s have been extensively investigated and are over-
expressed under conditions of stress and serve to pro-
tect proteins from damage during stress [8,9].
Hsp70 is present in the retina [10] and Desmettre
et al. [11] has shown that application of subtreshold
transpupillary TTT irradiation induces overexpression of
Hsp70 in a rabbit model of CNV. Here we have investi-
gated whether CNV membranes from AMD patients
express Hsp70 and whether the expression is modulated
by pre-treatment with TTT or PDT.
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Subretinal CNV tissue (Figure 1) was removed by pars
plana vitrectomy and maintained at -24°C until use. The
CNV tissue was embedded in Jung’s medium and sec-
tioned in 5 μm thick sections using a cryostat (Leitz
Lauda Kryostat 1720 Digital). The sections were
mounted on SuperFrost Plus glass slides, incubated with
blocking solution (5% BSA in PBS) for 1 hour at room
temperature in a humidified chamber followed by incu-
bation with an anti-Hsp/Hsc70 monoclonal antibody
(Chemicon
® International, Lot: 24060368). After over-
night incubation at 4°C (or 1 hour at 37°C) the sections
and HeLa cells (atcc number: CCL-2, LGC Promochem)
were washed with PBS (Tween 20) 2 times for 5 min-
utes and incubated for 1 hour with a biotinylated anti-
mouse secondary antibody (Polylink, Lot: C036, DCS
Innovative Diagnostic Systems). After washing twice for
5 minutes with PBS (Tween 20) the sections and the
HeLa cells were incubated with streptavidin-alkaline
phosphatase for 30 min at room temperature followed
by 2 × 5 minutes washes with PBS (tween 20), followed
by incubation with the chromogenic alkaline phospha-
tase. An avidin-biotin blocking kit was used to inhibit
endogenous avidin and biotin (BioGenex Laboratories).
To inhibit endogenous alkaline phosphatase levamisol
was used (Dako
®).
For negative controls (Figure 2), the primary antibody
was replaced by PBS. CNV membranes were stained
with Celestine and Eosin and embedded in Imagen
embedding medium (Dako Cytomation). Due to broad
spectrum tissue autofluorescene labeled antibodies could
not be used (Figure 3).
For light microscopic evaluation a Leica DM IRB
microscope was used. Images were captured with a
microscope-mounted camera( H i t a c h i3 C C DH V - C 2 0
AMP Color Camera) and processed with the PC soft-
ware, DISKUS microscopic documentation (Hilgers,
Germany).
Results
Of the fourteen CNV membranes from fourteen patients
(7 female 72,5 ± 11,5 years and 6 male 73,5 ± 10,5
years) with AMD examined for the presence of Hsp/
Hsc70, eleven membranes were Hsp70 positive, whereas
3 were Hsp/Hsc70 negative. The four membranes
obtained from PDT pre-treated patients were all positive
for Hsp/Hsc70 (Figure 4a, b) whereas of the two mem-
branes obtained from TTT pre-treated patients one was
positive and one was negative (Figure 4c, d). Of the
eight membranes obtained from non-treated patient six
were positive for Hsp/Hsc70 and two were negative
(Figure 4e, f).
In summary 79% of the fourteen membranes exam-
ined Hsp/Hsc70 positive.
Figure 1 Native cnv membrane. Native cnv membrane (bright
field, magnification 5×). Arrow indicates fibrovascular tissue.
Figure 2 HeLa Cells - HeLa Cells served as positive controls. a) Nearly confluently growing cells. As primary antibody Anti Hsp 70 was used.
Pink staining verifies presence of Hsp 70 (magnification 20×). Arrow: It appears that Hsp is localized mostly on the nuclear membrane. b) No
primary antibody was used. Missing immunoreactivity verifies antibody specifity (magnification 20 x).
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The presence of Hsc70/Hsp70 has been described in
the normal retina. Dean et al. [5] have shown that
Hsc70 immunoreactivity was present in all layers of
the retina, except in the photoreceptor outer segments
and the retinal pigment epithelium (RPE) whereas
Hsp70 immunoreactivity was restricted to the inner
segments of photoreceptors, the membrana limitans
externa and the outer nuclear layer. Dean et al. have
suggested that different eye structures are dependent
on different and specific heat shock proteins [12]. In
our laboratory we have found that Hsp70 is normally
present in all retinal layers, except the retinal pigment
epithelium.
In this study Hsp70 was detected in the majority of
CNV membranes secondary to AMD. The presence of
significant amounts of Hsp70 in the CNV membranes
indicates that the cellular components of the mem-
branes are cells (fiboblasts, endothelial cells, RPE cells,
etc.) that have been subjected to a stressful environ-
ment and inflammatory responses induced by CNV
membrane in its surrounding tissue. Furthermore, heat
shock proteins have been detected in various retinal
layers in animal models, indicating a physiologic role
in the eye. In a preliminary experiment, we tested our
antibody in a human donor eye and detected Hsp70 in
all retinal layers except the RPE. This could indicate a
wider role of heat shock proteins in retinal physiology,
but could also be due to retinal changes in a dying
human, especially to a breakdown of the blood-retina
barrier. Lafaut et al. [13] showed that the majority of
classic CNV membranes in AMD patients consisted of
subretinal, fibrovascular tissue and independent of the
underlying disease, CNV membranes exhibit similar
histological feature and can be seen as the result of
unspecific proliferation of fibrovascular tissue. CNV
membranes in our study showed similar histological
features described by Lafaut [13], including the pre-
sence of sporadic vessels, in which the endothelium
was positive for Hsp70.
Desmettre et al. [11] demonstrated an upregulation
of heat shock proteins in the chorioretinal layers 24
hours after TTT treatment in a rabbit model. Unfortu-
nately we had available only two membranes from
patients that had previously been treated with TTT
treatment and in addition the membranes were surgi-
cally excised weeks following TTT and it is therefore
not possible to make any assessment as to whether
Figure 3 Tissue autofluorescence. a - d) These figures show four non treated (native) CNV membranes at20 × magnification. a) Shows bright
field and Fig 3b-d the autofluorescence of lipofuscin in red, green and blue field. Although different wave length were used, tissue
autofluorescence is present at various wavelengths so that nucleus staining (DAPI) and Hsp70-detection could not be performed. Arrow indicates
the retinal pigment epithelium (RPE).
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proteins.
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following all the guidelines for experimental investiga-
tions required by the Institutional Review Board or
Ethics Committee.
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Figure 4 CNV membranes with PDT-/TTT- and non- pretreatment. PDT pretreated. a) PDT pretreated membrane which mostly consists of a
fibrovascular. tissue architecture. No immunoreactivity (negative control) without primary antibody (Anti Hsp70, magnification 20 x). The
surrounding pink staining reaction is an artefact (arrow). b) PDT pretreated membrane with immunoreactivity to the anti-Hsp70 primary antibody
(pink stained tissue). TTT pretreated. c) TTT pretreated membrane which mostly consists of a fibrovascular tissue architecture. No
immunoreactivity (negative control) without primary antibody (Anti Hsp70, magnification 20×). The surrounding pink staining reaction is an
artefact (arrow). d) TTT pretreated membrane with immunoreactivity to anti Hsp70 (pink stained tissue). No pretreatment. e) Non pretreated
membrane which mostly consists of a fibrovascular tissue architecture. No immunoreactivity (negative control). Without primary antibody (Anti
Hsp70, magnification 20 x). The surrounding pink staining reaction is an artefact (arrow). f) Immunoreactivity to anti-HSP70 antibody of an
untreated CNV membrane (pink stained tissue).
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